Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Deucravacitinib, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Deucravacitinib impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Deucravacitinib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Our Deucravacitinib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Deucravacitinib Related Compounds
Stable Isotopes
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| BMT-153261 | Stable Isotopes | CS-O-44076 | 1609393-48-7 | Enquire |
| Deucravacitinib(N,N-bis(methyl-d3))-d6 | Stable Isotopes | CS-O-60308 | ---- | Enquire |
| Deucravacitinib-13C-D3 | Stable Isotopes | CS-O-44401 | Not Available | Enquire |
| Deucravacitinib-D6 | Stable Isotopes | CS-O-53028 | ---- | Enquire |
| N-Nitroso Deucravacitinib Impurity 12 | Stable Isotopes | CS-O-54778 | ---- | Enquire |
| N-Nitroso Deucravacitinib-d3 | Stable Isotopes | CS-O-60033 | ---- | Enquire |
| N-Nitroso Deucravacitinib-D6 | Stable Isotopes | CS-O-54644 | ---- | Enquire |
API
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Deucravacitinib (methyl-d3) | API | CS-ED-02295 | 1609392-27-9 | In Stock |
| Deucravacitinib (non-labeled) | API | CS-ED-42221 | 2417137-50-7 | Enquire |
Metabolite
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| BMT-334616 | Metabolite | CS-O-44077 | Not Available | Enquire |
| Deucravacitinib M-11 metabolite | Metabolite | CS-O-44078 | ---- | Enquire |
Impurity
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2... | Impurity | CS-O-57321 | ---- | Enquire |
| 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2... | Impurity | CS-O-57322 | ---- | Enquire |
| BMT-158170 | Impurity | CS-O-48942 | 2417138-48-6 | Enquire |
| Deucravacitinib Acetamide impurity | Impurity | CS-O-57319 | ---- | Enquire |
| Deucravacitinib Acid impurity | Impurity | CS-O-57318 | 2245111-18-4 | Enquire |
| Deucravacitinib impurity (3-amino-2-methoxybenzothioamide) | Impurity | CS-O-56947 | ---- | Enquire |
| Deucravacitinib Impurity 1 | Impurity | CS-EO-03252 | 1609394-05-9 | Enquire |
| Deucravacitinib Impurity 12 | Impurity | CS-EO-03254 | 1609394-23-1 | Enquire |
| Deucravacitinib Impurity 23 | Impurity | CS-O-57320 | --- | Enquire |
| Deucravacitinib Impurity 28 | Impurity | CS-O-58342 | 1261798-87-1 | Enquire |
| Deucravacitinib Impurity 34 | Impurity | CS-O-60307 | 3030727-46-6 | Enquire |
| Deucravacitinib Impurity 5 | Impurity | CS-O-56946 | 2222717-56-6 | Enquire |
| Deucravacitinib Impurity 6 | Impurity | CS-EO-03253 | 1609394-08-2 | Enquire |
Intermediate
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Deucravacitinib 5-chloro-2-methoxy-aniline intermediate | Intermediate | CS-O-55534 | 3054860-97-5 | Enquire |
Fine Chemicals
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| 3-(1-Ethyl-1H-1,2,4-triazol-3-yl)-2-methoxyaniline | Fine Chemicals | CS-O-54591 | 2948391-22-6 | Enquire |